These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11759636)

  • 1. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
    Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
    Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the most cost-effective screening regimen for colon cancer?
    Griffith S; Kane KY
    J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
    Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
    DuPont AW; Arguedas MR; Wilcox CM
    Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of cost-effective strategies in colorectal cancer screening].
    Dervaux B; Eeckhoudt L; Lebrun T; Sailly JC
    Rev Epidemiol Sante Publique; 1992; 40(5):296-306. PubMed ID: 1480806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal cancer: the light at the end of the tunnel.
    Caprilli R; Taddei G
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):109-13. PubMed ID: 9646188
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and surveillance for colorectal cancer.
    Schnoll-Sussman F; Markowitz AJ; Winawer SJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):10-21. PubMed ID: 11049028
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
    Hur C; Simon LS; Gazelle GS
    Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is screening of colorectal cancer by endoscopy economically profitable?].
    Santavirta J
    Duodecim; 2001; 117(12):1240-4. PubMed ID: 12183926
    [No Abstract]   [Full Text] [Related]  

  • 17. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of colorectal cancer: indications and recommendations for a practical procedure].
    Porschen R
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):705-10. PubMed ID: 8237065
    [No Abstract]   [Full Text] [Related]  

  • 19. Fecal occult blood testing: best option for colorectal cancer screening in Asia?
    Sharma SP
    J Natl Cancer Inst; 2008 Aug; 100(15):1056-7. PubMed ID: 18664644
    [No Abstract]   [Full Text] [Related]  

  • 20. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy.
    Hassan C; Zullo A; Laghi A; Reitano I; Taggi F; Cerro P; Iafrate F; Giustini M; Winn S; Morini S
    Dig Liver Dis; 2007 Mar; 39(3):242-50. PubMed ID: 17112797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.